ACCESSION: MSBNK-SMB_Measured-HSA014P0480000
RECORD_TITLE: Annotated; LysoPE(18:0/0:0); LC-ESI-QFT; MS2; NEGATIVE; generated fron DDA dataset
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 14
COMMENT: RAW_SPEC {'EL16-neg_9511': {'bp': 258329.0, 'sum': 497609.0}, 'EL06-neg_9556': {'bp': 229259.0, 'sum': 450818.0}, 'EL02-neg_9587': {'bp': 221590.0, 'sum': 451248.0}, 'EL19-neg_9569': {'bp': 213636.0, 'sum': 407550.0}, 'EL17-neg_9531': {'bp': 208794.0, 'sum': 403318.0}, 'EL01-neg_9505': {'bp': 187038.0, 'sum': 387534.0}, 'EL18-neg_9516': {'bp': 171472.0, 'sum': 352828.0}, 'EL15-neg_9539': {'bp': 168520.0, 'sum': 335766.0}, 'EL14-neg_9515': {'bp': 145972.0, 'sum': 304725.0}, 'EL03-neg_9516': {'bp': 142783.0, 'sum': 295644.0}, 'EL20-neg_9541': {'bp': 134427.0, 'sum': 256502.0}, 'EL04-neg_9501': {'bp': 121756.0, 'sum': 253566.0}, 'EL08-neg_9530': {'bp': 113310.0, 'sum': 257734.0}, 'EL13-neg_9525': {'bp': 75477.0, 'sum': 165242.0}}
COMMENT: RETENTION_TIME_STDEV 0.009
COMMENT: PRECURSOR_M/Z_RAW 480.309503
COMMENT: PRECURSOR_M/Z_STDEV 0.000165
COMMENT: PRECURSOR_IN_MS1 mz 480.309439; int 62.452; delta(ppm) 1.034421
COMMENT: PROPOSED_CHARGE_STATE -1; mz 481.312780; int 15.264; cor 0.802
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 3.033; C24H44N5O3P; [M-H]1; delta(ppm) -3.033346
COMMENT: PROPOSED_MF SevenGoldenRules 0.256; C23H48NO7P; [M-H]1; delta(ppm) -0.255549
COMMENT: PROPOSED_MF SevenGoldenRules 3.177; C25H43N3O6; [M-H]1; delta(ppm) 3.176702
COMMENT: PROPOSED_MF MS-FINDER 4.016; C23H48NO7P; [M-H]-; delta(ppm) -0.254962
COMMENT: PROPOSED_MF MS-FINDER 3.235; C25H43N3O6; [M-H]-; delta(ppm) 3.184012
COMMENT: PROPOSED_MF MS-FINDER 2.804; C16H48N7O5PS; [M-H]-; delta(ppm) -1.682790
COMMENT: PROPOSED_MF MS-FINDER 2.801; C18H43N9O4S; [M-H]-; delta(ppm) 1.756174
COMMENT: PROPOSED_MF MS-FINDER 2.651; C26H39N7O2; [M-H]-; delta(ppm) 0.399518
COMMENT: PROPOSED_MF MS-FINDER 2.594; C22H47N3O6S; [M-H]-; delta(ppm) -3.834642
COMMENT: PROPOSED_MF MS-FINDER 2.538; C19H39N13S; [M-H]-; delta(ppm) -1.028312
COMMENT: PROPOSED_MF MS-FINDER 2.512; C11H43N15O2S2; [M-H]-; delta(ppm) 0.328341
COMMENT: PROPOSED_MF MS-FINDER 2.509; C24H44N5O3P; [M-H]-; delta(ppm) -3.039437
COMMENT: PROPOSED_MF MS-FINDER 2.507; C24H52NO2PS2; [M-H]-; delta(ppm) -2.064245
COMMENT: PROPOSED_MF MS-FINDER 2.374; C11H35N19O3; [M-H]-; delta(ppm) -0.646856
COMMENT: PROPOSED_MF MS-FINDER 2.294; C12H44N13O3PS; [M-H]-; delta(ppm) 3.908050
COMMENT: PROPOSED_MF MS-FINDER 2.212; C18H51N5O3S3; [M-H]-; delta(ppm) 2.731376
COMMENT: PROPOSED_MF MS-FINDER 2.033; C27H48NO2PS; [M-H]-; delta(ppm) 4.954433
COMMENT: PROPOSED_MF MS-FINDER 2.024; C26H47N3OS2; [M-H]-; delta(ppm) 1.374716
COMMENT: PROPOSED_MF MS-FINDER 1.980; C18H59NO2S5; [M-H]-; delta(ppm) 3.706579
COMMENT: PROPOSED_MF SIRIUS5_Sirius 16.745; C23H48NO7P; [M-H]-; delta(ppm) -0.254962
COMMENT: PROPOSED_MF SIRIUS5_Sirius 9.204; C25H43N3O6; [M-H]-; delta(ppm) 3.184012
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.633; C30H43NO4; [M-H]-; delta(ppm) -5.191283
COMMENT: PROPOSED_MF SIRIUS5_Sirius 6.155; C27H44FNO5; [M-H]-; delta(ppm) -7.570248
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C23H48NO7P; [M-H]-; delta(ppm) -0.254962
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.524; C23H48NO7P; [M-H]-; delta(ppm) -0.254962
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.828; C22H44FN3O7; [M-H]-; delta(ppm) 0.805007
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.399; C25H43N3O6; [M-H]-; delta(ppm) 3.184012
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.210; C19H44N7O5P; [M-H]-; delta(ppm) 5.335894
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.828; C30H43NO4; [M-H]-; delta(ppm) -5.191283
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.721; C23H40FN7O3; [M-H]-; delta(ppm) -1.979474
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.406; C25H43F4NO3; [M-H]-; delta(ppm) -2.479256
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.094; C24H44N5O3P; [M-H]-; delta(ppm) -3.039437
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.970; C24H48ClNO6; [M-H]-; delta(ppm) -47590.397216
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.818; C21H39N9O4; [M-H]-; delta(ppm) 8.774906
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.991; C23H48NO7P; [M-H]-; delta(ppm) -0.254962
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.005; C19H44N7O5P; [M-H]-; delta(ppm) 5.335894
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.002; C22H44FN3O7; [M-H]-; delta(ppm) 0.805007
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C23H40FN7O3; [M-H]-; delta(ppm) -1.979474
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C30H43NO4; [M-H]-; delta(ppm) -5.191283
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C25H43F4NO3; [M-H]-; delta(ppm) -2.479256
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C24H48ClNO6; [M-H]-; delta(ppm) -47590.397216
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 7.000; BBYWOYAFBUOUFP-JOCHJYFZSA-N; C23H48NO7P; Spectral Match to 1-Stearoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine from NIST14
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.371; BBYWOYAFBUOUFP-JOCHJYFZSA-N; [M-H]-; CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(O)(=O)OCCN
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.368; KIHAGWUUUHJRMS-JOCHJYFZSA-N; [M-H]-; CCCCCCCCCCCCCCCCCC(=O)O[C@H](CO)COP(O)(=O)OCCN
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.919; LEBRETLBLINJDM-HSZRJFAPSA-N; [M-H]-; CCCCCCCCCCCCCCCCOC[C@H](COP([O-])(=O)OCC[NH3+])OC(C)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.700; RJZVWDTYEWCUAR-JOCHJYFZSA-N; [M-H]-; CCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.580; GBZWEJDRTZPHRK-HUXSXENDSA-N; [M-H]-; CC(C)CCC(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.825; BBYWOYAFBUOUFP-JOCHJYFZSA-N; [M-H]-; LysoPE(18:0/0:0)
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.674; KIHAGWUUUHJRMS-JOCHJYFZSA-N; [M-H]-; LysoPE(0:0/18:0)
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.426; RJZVWDTYEWCUAR-JOCHJYFZSA-N; [M-H]-; LysoPC(15:0)
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.299; LEBRETLBLINJDM-HSZRJFAPSA-N; [M-H]-; 1-hexadecyl-2-acetyl-sn-glycero-3-phosphoethanolamine zwitterion
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.119; SKOJWJADWCAPSY-ZREVVVSZNA-N; [M-H]-; Stellettacholine B;(-)-Stellettacholine B
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.483; SHBAKEKBTCPUFI-OUJCMCIWSA-N; [M-H]-; [(2R,3S,4S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hexadecanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.166; DIJCCOGBPIXGPC-UHFFFAOYSA-N; [M-H]-; CNP0430365
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.886; XBUOPSRCSMOVAD-UHFFFAOYSA-N; [M-H]-; 5-[2-(3-acetamidopyrrolidin-1-yl)-2-oxoethyl]-6-hydroxy-1-(hydroxymethyl)-1,4a-dimethyl-decahydronaphthalen-2-yl N-propylcarbamate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.885; JVIPHQOMYSTEIN-UHFFFAOYSA-N; [M-H]-; 4-({[1-(2-{[(tert-butoxy)carbonyl]amino}-4-methylpentanoyl)piperidin-4-yl]formamido}methyl)cyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.884; RYILBHSUHOGUJC-UHFFFAOYSA-N; [M-H]-; 4-({[1-(2-{[(tert-butoxy)carbonyl]amino}-3-methylpentanoyl)piperidin-4-yl]formamido}methyl)cyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.856; XEFNBUBDJCJOGM-OUJCMCIWSA-N; [M-H]-; N-[1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]hexadecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; BBYWOYAFBUOUFP-JOCHJYFZSA-N; [M-H]-; LysoPE(18:0/0:0)
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; KIHAGWUUUHJRMS-JOCHJYFZSA-N; [M-H]-; LysoPE(0:0/18:0)
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; SHBAKEKBTCPUFI-OUJCMCIWSA-N; [M-H]-; [(2R,3S,4S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hexadecanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.782; DIJCCOGBPIXGPC-UHFFFAOYSA-N; [M-H]-; CNP0430365
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.767; LEBRETLBLINJDM-HSZRJFAPSA-N; [M-H]-; 1-hexadecyl-2-acetyl-sn-glycero-3-phosphoethanolamine zwitterion
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.620; RJZVWDTYEWCUAR-JOCHJYFZSA-N; [M-H]-; LysoPC(15:0)
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.082; XEFNBUBDJCJOGM-OUJCMCIWSA-N; [M-H]-; N-[1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]hexadecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; JVIPHQOMYSTEIN-UHFFFAOYSA-N; [M-H]-; 4-({[1-(2-{[(tert-butoxy)carbonyl]amino}-4-methylpentanoyl)piperidin-4-yl]formamido}methyl)cyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; RYILBHSUHOGUJC-UHFFFAOYSA-N; [M-H]-; 4-({[1-(2-{[(tert-butoxy)carbonyl]amino}-3-methylpentanoyl)piperidin-4-yl]formamido}methyl)cyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; XBUOPSRCSMOVAD-UHFFFAOYSA-N; [M-H]-; 5-[2-(3-acetamidopyrrolidin-1-yl)-2-oxoethyl]-6-hydroxy-1-(hydroxymethyl)-1,4a-dimethyl-decahydronaphthalen-2-yl N-propylcarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.082; XEFNBUBDJCJOGM-OUJCMCIWSA-N; [M-H]-; N-[1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]hexadecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; BBYWOYAFBUOUFP-JOCHJYFZSA-N; [M-H]-; [(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] octadecanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.387; SHBAKEKBTCPUFI-OUJCMCIWSA-N; [M-H]-; [(2R,3S,4S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hexadecanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.509; KIHAGWUUUHJRMS-JOCHJYFZSA-N; [M-H]-; [(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hydroxypropan-2-yl] octadecanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.017; LEBRETLBLINJDM-HSZRJFAPSA-N; [M-H]-; [(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.513; GWPSWVKRTQYSAW-JOCHJYFZSA-N; [M-H]-; [(2R)-2,3-dihydroxypropyl] 2-(octadecanoylamino)ethyl hydrogen phosphate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; LHJYPOXVVYJDHU-UHFFFAOYSA-N; [M-H]-; 2-[2-(2-butoxy-3-methoxyphenyl)ethyl-[2-(propylcarbamoyloxy)ethyl]amino]ethyl N-propylcarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -2.666; BBYWOYAFBUOUFP; [M-H]-; 1-stearoyl-phosphatidylethenolamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -40.185; RJZVWDTYEWCUAR; [M-H]-; Lysophosphatidylcholine(15:0/0:0)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -47.347; KIHAGWUUUHJRMS; [M-H]-; Lysophosphatidylethanolamine(0:0/18:0)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -68.140; LEFGRTKRNXPBLH; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -83.572; YSZRVLWZLLULHT; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -89.401; LEBRETLBLINJDM; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -157.642; SKOJWJADWCAPSY; [M-H]-; [3-(2,12-dimethyltridecanoyloxy)-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -162.254; GWPSWVKRTQYSAW; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.274; BBYWOYAFBUOUFP; [M-H]-; 1-stearoyl-phosphatidylethenolamine
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match LysoPE(18:0/0:0), BBYWOYAFBUOUFP-JOCHJYFZSA-N; Matching to 7 measured spectra (Dot product > 0.7); Proposed by SIRIUS5_CSI with FDR < 0.05; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (1), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (1), MetFrag:PubchemLite (2); This structural isomer was suggested from the biological context HMDB HMDB0011130;
CH$NAME: LysoPE(18:0/0:0)
CH$NAME: [(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] octadecanoate
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C23H48NO7P
CH$EXACT_MASS: 481.316840
CH$SMILES: CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)O
CH$IUPAC: InChI=1S/C23H48NO7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-23(26)29-20-22(25)21-31-32(27,28)30-19-18-24/h22,25H,2-21,24H2,1H3,(H,27,28)/t22-/m1/s1
CH$LINK: CHEBI CHEBI:75036
CH$LINK: HMDB HMDB0011130
CH$LINK: INCHIKEY BBYWOYAFBUOUFP-JOCHJYFZSA-N
CH$LINK: LIPIDMAPS LMGP02050001
CH$LINK: PUBCHEM CID:9547068
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 16.338
MS$FOCUSED_ION: ION_TYPE [M-H]-
MS$FOCUSED_ION: PRECURSOR_M/Z 480.309439
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-001i-1190100000-af79e055f324b161f028
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  78.9576212 192.1408 78.957609 0.5066 24.05 0.9341 14 ?
  116.9272365 63.6862 116.927278 1.5138 62.32 -0.7273 12 ?
  140.0107017 55.3888 140.010794 1.3570 7.74 0.9121 14 f{C2H7N1O4P1}/-7.96ppm,p-C21H40O3
  196.0379756 98.8797 196.037409 1.0916 11.46 0.8725 14 f{C5H11N1O5P1}/-0.28ppm,p-C18H36O2
  214.0490239 20.3476 214.048631 1.1119 5.87 0.4667 10 f{C12H8N1O3}/-9.08ppm,p-C11H39O4P1
  283.2642243 999.0000 283.264434 0.4095 0.00 0.9385 14 f{C18H35O2}/-0.10ppm,p-C5H12N1O5P1
  284.2675635 181.2549 284.267776 0.6191 14.13 0.9473 14 ?
  480.3093903 212.2695 480.309951 1.1451 24.32 1.0000 14 f{C23H47N1O7P1}/-0.36ppm,p
PK$NUM_PEAK: 8
PK$PEAK: m/z int. rel.int.
  78.957621 192.14 192
  116.927236 63.69 63
  140.010702 55.39 55
  196.037976 98.88 98
  214.049024 20.35 20
  283.264224 999.00 999
  284.267563 181.25 181
  480.309390 212.27 212
//
